Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics
PR Newswire —
Agreement establishes first ultra-low temperature cold chain in veterinary medicine ahead of anticipated potential first FDA-approved, off-the-shelf stem cell therapy SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Gallant, an animal health biotechnology company pioneering off-the-shelf stem...